Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Post by barmac6on Jan 17, 2012 1:57pm
474 Views
Post# 19413122

Hem with a a Debt-to-Capital ratio of 0.2%

Hem with a a Debt-to-Capital ratio of 0.2%

China Techfaith Wireless Communication Technology has the Lowest Debt-to-Capital Ratio in the Communications Equipment Industry (CNTF, HEMGF, ITRN, AFOP, EXFO)

 
By Nick Russo

Below are the three companies in the Communications Equipment industry with the lowest Debt-to-Capital ratios. The debt-to-capital ratio is an important measure of how a company is financing its operations along with some insight into its financial strength, relative to other companies in its industry.

China Techfaith Wireless Communication Technology ranks lowest with a a Debt-to-Capital ratio of 0.1%. Hemisphere GPS is next with a a Debt-to-Capital ratio of 0.2%. Ituran Location and Control ranks third lowest with a a Debt-to-Capital ratio of 0.3%.

Alliance Fiber Optic Products follows with a a Debt-to-Capital ratio of 0.4%, and Exfo Electro Optical Engineering rounds out the bottom five with a a Debt-to-Capital ratio of 0.9%.

SmarTrend is monitoring the recent change of momentum in Exfo Electro Optical Engineering. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Exfo Electro Optical Engineering in search of a potential trend change.

 

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse